Levine James E.'s Form 4 filing
Cardiff Oncology, Inc. (CRDF) · filed Sep 13, 2021
- Accession no.
- 0001628280-21-018433
- Filed
- Sep 13, 2021
- Trade date
- Sep 10, 2021
- Filing delay
- 3 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 5 non-derivative transactions and 0 derivative transactions. Open-market purchases total $194.0K. It was filed 3 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Levine James E.CIK 0001463151 | Officer (Chief Financial Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 10, 2021 | Common Stock | PPurchaseAcquired | +5,000 | $6.62 | +$33,100 | 5,000 | Direct | |
| Sep 10, 2021 | Common Stock | PPurchaseAcquired | +5,000 | $6.75 | +$33,750 | 10,000 | Direct | |
| Sep 10, 2021 | Common Stock | PPurchaseAcquired | +10,000 | $6.38 | +$63,800 | 20,000 | Direct | |
| Sep 10, 2021 | Common Stock | PPurchaseAcquired | +5,000 | $6.35 | +$31,750 | 25,000 | Direct | |
| Sep 10, 2021 | Common Stock | PPurchaseAcquired | +5,000 | $6.32 | +$31,600 | 30,000 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.